載入...
Preclinical immunogenicity and safety of a Group A streptococcal M protein-based vaccine candidate
Streptococcus pyogenes (group A streptococcus, GAS) causes a wide range of clinical manifestations ranging from mild self-limiting pyoderma to invasive diseases such as sepsis. Also of concern are the post-infectious immune-mediated diseases including rheumatic heart disease. The development of a va...
Na minha lista:
| 發表在: | Hum Vaccin Immunother |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5215552/ https://ncbi.nlm.nih.gov/pubmed/27541593 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2016.1222999 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|